DES and invasive breast carcinoma: In addition, hATT-CMs were also enriched in complement component 3 (C3) (20-fold change), involved in the activation of the complement system, and in vimentin and desmin (8.5-fold and 6.5 fold change), which are mesenchymal cell proteins related to an invasive breast cancer phenotype.